Kertaannos

Kertaannos, commonly written kerta-annos in Finnish medical usage, refers to a single dose of a medicinal product administered to a patient in one occasion. It denotes an exposure to the drug that is intended to be sufficient to achieve the therapeutic effect without a second administration as part of that dosing episode. It is contrasted with repeated dosing schedules.

Medically, a kertaannos can be delivered through various routes, including oral tablets or capsules, injections, topical applications, inhalations, or single-dose vials and prefilled syringes designed for one-time use. The choice depends on the drug’s properties, the clinical setting, and goals such as rapid onset or convenient administration.

Pharmacokinetics and safety considerations are central to deciding whether a single dose is appropriate. Factors include absorption, distribution, metabolism, and elimination, as well as duration of action. A kertaannos aims to produce adequate drug exposure with a single administration, but variability between patients can affect efficacy and risk of adverse effects. Dosing accuracy and potential drug interactions remain important concerns.

Regulatory labeling and clinical guidelines may specify the dose as a single-dose or one-time administration. The term commonly appears in Finnish pharmacology literature, and standard spelling is kerta-annos; some texts may use the concatenated form kertaannos. The concept is relevant across fields such as analgesia, antibiotics with single-dose regimens, vaccines, and emergency medicine.